<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To identify the genetic determinants of colon <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, 268 male mice from 33 inbred strains derived from different genealogies were treated with azoxymethane (AOM; 10 mg/kg) once a week for six weeks to induce <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> were localized exclusively within the distal colon in each of the strains examined </plain></SENT>
<SENT sid="2" pm="."><plain>Inbred mouse strains exhibit a large variability in genetic susceptibility to AOM-induced colon <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The mean <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumor</z:e> multiplicity ranged from 0 to 38.6 (mean = 6.5 ± 8.6) and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> volume ranged from 0 to 706.5 mm(3) (mean = 87.4 ± 181.9) at 24 weeks after the first dose of AOM </plain></SENT>
<SENT sid="4" pm="."><plain>AOM-induced <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumor</z:e> phenotypes are highly heritable in inbred mice, and 68.8% and 71.3% of total phenotypic variation in <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumor</z:e> multiplicity and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> volume, respectively, are attributable to strain-dependent genetic background </plain></SENT>
<SENT sid="5" pm="."><plain>Using 97,854 single-nucleotide polymorphisms, we carried out a genome-wide association study (GWAS) of AOM-induced colon <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and identified a novel susceptibility locus on chromosome 15 (rs32359607, P = 6.31 × 10(-6)) </plain></SENT>
<SENT sid="6" pm="."><plain>Subsequent fine mapping confirmed five (Scc3, Scc2, Scc12, Scc8, and Ccs1) of 16 linkage regions previously found to be associated with <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumor</z:e> susceptibility </plain></SENT>
<SENT sid="7" pm="."><plain>These five loci were refined to less than 1 Mb genomic regions of interest </plain></SENT>
<SENT sid="8" pm="."><plain>Major candidates in these loci are Sema5a, Fmn2, Grem2, Fap, Gsg1l, Xpo6, Rabep2, Eif3c, Unc5d, and Gpr65 </plain></SENT>
<SENT sid="9" pm="."><plain>In particular, the refined Scc3 locus shows high concordance with the human GWAS locus that underlies hereditary mixed <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> syndrome </plain></SENT>
<SENT sid="10" pm="."><plain>These findings increase our understanding of the complex genetics of colon <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, and provide important insights into the pathways of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> development and might ultimately lead to more effective individually targeted <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention strategies </plain></SENT>
</text></document>